Gilead Sciences (GILD) Operating Margin (2009 - 2026)

Gilead Sciences has reported Operating Margin for 18 years, with the latest figure at 37.16% in Q1 2026.

• For the quarter ending Q1 2026, Operating Margin rose 360.0% year-over-year to 37.16%; the trailing twelve-month figure through Mar 2026 stood at 34.88% (up 627.0% YoY), and the FY2025 full-year result was 34.04%, up 2826.0% from the prior year.
• Operating Margin for Q1 2026 stood at 37.16%, up from 25.03% in the prior quarter.
• The five-year high for Operating Margin was 42.82% in Q3 2025, with the low at 64.64% in Q1 2024.
• Historically, Operating Margin has averaged 24.08% across 5 years, with a median of 32.4% in 2024.
• Annual changes were most pronounced in 2024 — Operating Margin sank 9148 bps — and 2025, when it soared 9820 bps.
• Gilead Sciences' Operating Margin stood at 30.68% in 2022, then decreased by 26 bps to 22.66% in 2023, then surged by 43 bps to 32.4% in 2024, then dropped by 23 bps to 25.03% in 2025, then jumped by 48 bps to 37.16% in 2026.
• The last three Operating Margin figures came in at 37.16% (Q1 2026), 25.03% (Q4 2025), and 42.82% (Q3 2025), per Business Quant data.